Work

Real-world survival outcomes with first-line venetoclax therapy in AML

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-1660

Authors: Nia M. Mitchell, Allison O. Taylor, Cheryl H. Chang, Rebecca Bystrom, Carlos de Castro, Harry Erba, Sanghee Hong, Chenyu Lin, Steven Wolf, Susan C. Locke, Thomas LeBlanc

Institutions: Duke University, Duke University Hospital, Duke Medical Center, Duke Cancer Institute

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417015695

Cites:

Cited by:

Related to: